Department of Medical Oncology, San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.
Crit Rev Oncol Hematol. 2013 Dec;88(3):564-72. doi: 10.1016/j.critrevonc.2013.07.010. Epub 2013 Aug 13.
Extraneural dissemination of oligodendroglioma is rare. Cases of breast metastases have never been described in the literature.
We report the first two cases of young women with initial diagnosis of anaplastic oligodendroglioma who experienced mammary gland metastases and a review of the literature.
Immunohistochemical analysis performed on material from both primary and metastatic sites did not allow to draw any conclusion on possible etiopathogenetic hypothesis. A review of literature yielded 35 cases of extracranial metastatic oligodendroglioma from 1989 to 2012.
Though rare, extracranial dissemination from oligodendroglioma may occur not only in long surviving heavily pre-treated patients. The review of literature and these two cases suggest that spread is primarily to bone and then from bone to other organs through hematogenous route mostly due to leptomeningeal or dura mater invasion. Chemotherapy regimens similar to those commonly used for non metastatic oligodendroglioma are recommended for patients with good performance status.
少突胶质细胞瘤的颅外播散较为罕见。文献中从未描述过乳房转移的病例。
我们报道了两例年轻女性患者,她们最初被诊断为间变性少突胶质细胞瘤,后来出现了乳腺转移,同时对文献进行了回顾。
对原发和转移部位的组织进行免疫组化分析,无法得出任何可能的病因假说。文献回顾显示,1989 年至 2012 年间共有 35 例颅外转移性少突胶质细胞瘤病例。
尽管罕见,但少突胶质细胞瘤的颅外播散不仅发生在长期生存、大量预处理的患者中。文献回顾和这两个病例表明,转移主要通过血行途径从骨骼扩散到其他器官,主要是由于软脑膜或硬脑膜侵犯。对于一般状况良好的患者,建议采用与非转移性少突胶质细胞瘤常用的化疗方案相同的方案。